Diversion control quota program
Ended Definitive Contract Awarded Last action
- Contract number
- 15DDHQ23C00000001
- Awardee
-
Deloitte & Touche LLP UEI F9KSDU7L9VP6
- Awarding agency
-
Drug Enforcement Administration
Department of Justice
- Obligated
- $2,711,290
Award facts
- Opportunity
-
- Quotas for Schedule I and II Controlled Substances Pre-Solicitation · 15DDHQ22R00000014 · Posted Jul 28, 2022
- Contract value 100% obligated
- $2,711,290.05 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 541611 Administrative Management and General Management Consulting Services
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Negotiated Proposal / Quote
- Pricing
- Time and Materials
- Place of performance
- Arlington, VA 22209, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | -$1,692,597 | |
| Terminate for Convenience | $0 | |
| Other Administrative Action | $0 | |
| Funding Only Action | $1,736,541 | |
| Other Administrative Action | $1,200,000 | |
| Change Order | $0 | |
| Supplemental Agreement for work within scope | $299,556 | |
| Other Administrative Action | $0 | |
| Funding Only Action | $1,017,930 | |
| Exercise an Option | $0 | |
| Change Order | $0 | |
| Original award | $149,860 |
Show all 12
About this award
This is a definitive contract awarded by the Drug Enforcement Administration (DEA) to Deloitte & Touche LLP, a prominent professional services firm, to provide consultation services supporting the DEA Administrator's future mission requirements for the Diversion Control Quota Program (DRQ). The contract has a ceiling value of $2,711,290.05 and a period of performance through February 12, 2026. The contract was awarded on a time and materials basis, without any set-aside designation. The contract requires Deloitte to develop new models, data sets, and approaches for establishing and revising aggregate production quotas for Schedule I and II controlled substances, as well as individual quotas for DEA-registered manufacturers. Deloitte may also be selected to provide ongoing advisory services to assist the DEA with implementation of the new quota systems. This contract supports the DEA's mission to control the diversion of controlled substances.
Quick answers
Who was awarded contract 15DDHQ23C00000001?
15DDHQ23C00000001 was awarded to Deloitte & Touche LLP by Drug Enforcement Administration (Department of Justice) on January 3, 2023.
How much is contract 15DDHQ23C00000001 worth?
The government has obligated $2,711,290 on 15DDHQ23C00000001.
Was contract 15DDHQ23C00000001 competed?
The extent of competition for 15DDHQ23C00000001 was full and open competition. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award